Pfizer Begins Clinical Trial Of COVID-19 Antiviral Paxlovid In Kids
The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.
Posted at 1:59 PM, Mar 09, 2022
Copyright 2024 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
-
Ozempic maker sets clinical trial to study drug's effect on alcohol consumption
7:39 PM, May 20, 2024 -
Weight loss drugs not just being used by those to treat chronic conditions, survey finds
2:13 PM, May 20, 2024 -
Public health alert issued after HIV-positive sex worker had over 200 clients
12:24 PM, May 20, 2024